The Beauty Health Company

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

The Beauty Health Company reports robust Q4 earnings and eyes international expansion opportunities

The Beauty Health Company delivered strong financial results in Q4 2022, showcasing consistent growth and profitability across regions.
Despite challenges like lower system ASP and heavy investments, the company's strategic initiatives and financial strength position it well for future growth.
Opportunities in international expansion, product portfolio enhancement, and market growth present avenues for sustained success in 2023 and beyond.
With a focus on operational efficiency, market adaptability, and category leadership, The Beauty Health Company remains poised for continued growth and profitability.

The Beauty Health Company (SKIN) reports robust Q1 performance and optimistic outlook for 2023

The Beauty Health Company (SKIN) showcased strong Q1 performance despite challenges, with a positive outlook for the year. The company's growth strategy, including the Cyndea system launch and boosters attachment rates, positions it well for future success.

Beauty Health Co. reports strong Q2, eyes global growth opportunities

The Beauty Health Company delivered strong Q2 results, reaffirming guidance despite challenges with Syndeo issues and gross margin pressure.
The company's focus on innovation, market resilience, and strategic investments positions it well for future growth and product expansion.
Opportunities in international markets, product enhancements, and margin improvement strategies present avenues for sustained performance and profitability.
Addressing challenges with Syndeo issues and gross margin pressure while leveraging market strengths and opportunities will be key to the company's continued success.

Beauty Health Co. addresses Syndeo challenges, focuses on growth

The Beauty Health Company is navigating challenges with Syndeo while focusing on customer-centric strategies and operational excellence under new leadership. Despite financial setbacks, the company aims for cost savings and growth opportunities through strategic transformation and reaccelerating Syndeo adoption in the U.S.

The Beauty Health Company reports solid Q4 performance and eyes growth in China market

The Beauty Health Company's Q4 2023 performance reflects revenue growth driven by APAC and EMEA, with operational efficiency and cost savings initiatives.
Strategic strengths include a strong cash position, inventory optimization efforts, and growth opportunities in the Chinese market.
Challenges include quality control issues, revenue declines in certain regions, and short-term financial pressures to be managed effectively.
Opportunities lie in expanding product offerings in China, improving gross margins, and addressing quality concerns to drive sustainable growth.

The Beauty Health Company (SKIN) surpasses Q1 targets, eyes growth

SKIN's Q1 performance exceeded expectations, with strong revenue and EBITDA figures, driven by consumables growth and operational improvements.
While facing challenges in equipment sales and product costs, SKIN's focus on excellence and growth opportunities position the company well for the future.
Analyst inquiries highlighted areas for improvement, but Marla Beck's confidence in growth avenues underscores a positive outlook for SKIN.

The Beauty Health Company (SKIN) exceeds Q3 revenue guidance, navigates market challenges

SKIN's Q3 2024 performance showcased revenue above guidance, profitability, and strategic advancements in sales, operations, and innovation.
While facing revenue declines and market challenges, SKIN's focus on profitability, margin expansion, and operational effectiveness signals a commitment to long-term success.
Navigating challenges with a proactive approach and seizing growth opportunities can position SKIN for sustained success and market resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Allogene Therapeutics Inc

Chewy

Clear Secure

Beyond Meat

Carvana

World Acceptance

While trading with the masses may generally be the wisest approach, contrarian gamblers may accrue dramatic profitability through short-squeeze stocks. To get everyone on the same page, coordinated investments in heavily shorted securities can potentially trigger ridiculous upside as bears panic out of their positions.

7 Short-Squeeze Stocks That Could Make You Rich

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the international launch of Hydrafacial™ Syndeo™, the award-winning next generation connected delivery system. The expansion brings Syndeo to Europe and Asia, following the device's successful U.S. debut in March 2022 and a first year of booming sales.

Revolutionizing the Treatment Room: BeautyHealth Launches Connected Hydrafacial Syndeo Device in Europe and Asia

Beauty Health Co (NASDAQ:SKIN ) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Eduardo Rodriguez - Senior Director, M&A and IR Andrew Stanleick - President, CEO & Director Liyuan Woo - CFO Conference Call Participants Bruce Jackson - The Benchmark Company Jonathan Block - Stifel, Nicolaus & Company Olivia Tong - Raymond James & Associates Linda Bolton-Weiser - D.A. Davidson & Co. Korinne Wolfmeyer - Piper Sandler & Co. Allen Gong - JPMorgan Chase & Co. Kyle Rose - Canaccord Genuity Navann Ty - BNP Paribas Exane Margaret Kaczor - William Blair & Company Operator Good morning, and welcome to The Beauty Health Company's Fourth Quarter and Fiscal Year 2022 Earnings Conference Call.

Beauty Health Co (SKIN) Q4 2022 Earnings Call Transcript

The medical device company is gaining traction with growing sales and profits.

Why Is The Beauty Health Company Jumping Higher Today?

The Beauty Health Company (SKIN) delivered earnings and revenue surprises of 0% and 3.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

The Beauty Health Company (SKIN) Q4 Earnings Meet Estimates

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2022. Full year 2022 net sales of $365.9 million increased +41% relative to 2021, and fourth quarter net sales of $98.1 million increased +26%, revealing consistent mid-to-high double-digit quarterly growth year-over-year. The Company delivered net income of $44.

BeautyHealth Reports Full Year and Fourth Quarter 2022 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand HydrafacialTM, today announced a definitive agreement to acquire SkinStylus®, an FDA-cleared microneedling device. The agreement represents a key step forward in BeautyHealth's portfolio build-up strategy and ultimately its vision to become the world's leading beauty, health and wellness platform, fueled by a community of engaged providers, estheticians and consumers.

BeautyHealth to Acquire SkinStylus®, FDA-Cleared Microneedling Device

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced it will report fourth quarter and full-year fiscal 2022 results before market open on Tuesday, February 28, 2023. The company will host an investor conference call at 8:30 a.m. Eastern Time, following a press release detailing the results. Investors and analysts interested in participating in the call are invited to join via webcast at https://investors.beautyhealth.

BeautyHealth to Report Fourth Quarter and Full-Year Fiscal 2022 Financial Results on February 28, 2023

Cemtrex

Oragenics

Sientra

Sitio Royalties Corp

Warby Parker

As much as we may recognize that short sellers perform a valuable service for the equities market, the concept of targeting short-squeeze stocks to buy just to penalize the pessimists carries cathartic value. Fundamentally, market bears operate like great white sharks.

7 Short-Squeeze Stocks to Buy Before They Soar

In 2023, revenue should benefit from healthy demand and an increasing footprint globally. Margins should benefit from operating leverage and normalized investment levels in 2023.

The Beauty Health Company: A Good Long Term Bet

LONG BEACH, Calif.--( BUSINESS WIRE )--Beloved professional skincare treatment Hydrafacial is now clinically reported to improve acne skin concerns, according to a new study published in the peer-reviewed Journal of Clinical and Aesthetic Dermatology (JCAD). The Beauty Health Company-owned brand (NASDAQ: SKIN) shared that 100 percent of study participants reported clearer, less inflamed skin after a series of clarifying treatments with Hydrafacial's patented vortex fusion device and blue LED light.

New Clinical Study Finds Hydrafacial Clarifying Treatments Improve Acne Skin Concerns in 100 Percent of Participants

Bed Bath & Beyond

Heron Therapeutics

Marathon Digital Holdings

Silvergate Capital Corp

Upstart Holdings

Wayfair

Shorting stocks is still a viable strategy for experienced investors who are active in the stock market. Here is a look back at the most shorted stocks of December 2022.

Looking Back At The 10 Most Shorted Stocks Of December 2022

LONG BEACH, Calif.--( BUSINESS WIRE )--The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today launched a new booster co-created with BABOR Skincare, which leverages DOCTOR BABOR's technology to help increase hydration levels for a smoother, lifted and more youthful-looking complexion.

BeautyHealth's Hydrafacial Launches New Booster Developed with BABOR Laboratories in Germany

LONG BEACH, Calif.--( BUSINESS WIRE )--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that President and Chief Executive Officer Andrew Stanleick and Chief Financial Officer Liyuan Woo will participate in a fireside chat at the Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022 at 9:10 a.m. ET in New York, NY.

BeautyHealth to Participate in Stifel 2022 Healthcare Conference

BeautyHealth Enters Into $100 Million Accelerated Share Repurchase Agreement

The Beauty Health Company (NASDAQ:SKIN ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Eduardo Rodriguez - Senior Director of M&A and IR Andrew Stanleick - President and CEO Liyuan Woo - CFO Conference Call Participants Oliver Chen - Cowen Korinne Wolfmeyer - Piper Sandler Jon Block - Stifel Margaret Kaczor - William Blair Allen Gong - JPMorgan Ashley Helgans - Jefferies Kyle Rose - Canaccord Genuity Bruce Jackson - The Benchmark Company Devin Weinstein - Raymond James Linda Bolton Weiser - D.A. Davidson Operator Ladies and gentlemen, good morning, and welcome to Beauty Health Company Third Quarter 2022 Earnings Call.

The Beauty Health Company (SKIN) Q3 2022 Earnings Call Transcript

BeautyHealth Reports Third Quarter 2022 Financial Results

BeautyHealth's Hydrafacial Announces Co-Creation Partnership with Dr. Dennis Gross Skincare for Innovative New Booster

BeautyHealth's Hydrafacial Rolls Out New Triple AHA Exfoliating Booster with Professional Skincare Brand Glytone

BeautyHealth Appoints David Aquino as Executive Vice President Global Operations

BeautyHealth to Report Third Quarter 2022 Financial Results on November 8, 2022

The Beauty Health Company's new mid-term targets highlight the impressive (but achievable) growth opportunities at hand. As the model benefits from operating leverage, more revenue growth should yield significant margin expansion as well.

The Beauty Health Company: A Compelling Mid To Long-Term Growth Story

LONG BEACH, Calif.--(BUSINESS WIRE)--Highly Anticipated Hydrafacial x JLo Beauty Booster Now Available in the U.S.

Get ready to GLOW! Highly Anticipated Hydrafacial x JLo Beauty Booster Now Available in the U.S.

BeautyHealth's HydraFacial platform is popular, management is building a solid track record, and the business is outperforming expectations.

This High-Growth, Under-the-Radar Stock Has 80% Upside, According to Wall Street

The Beauty Health Company (SKIN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

The Beauty Health Company (SKIN) Stock Jumps 11.4%: Will It Continue to Soar?

News for The Beauty Health Company Stock (SKIN)